155 related articles for article (PubMed ID: 37663945)
1. Fecal microbial biomarkers combined with multi-target stool DNA test improve diagnostic accuracy for colorectal cancer.
Fan JQ; Zhao WF; Lu QW; Zha FR; Lv LB; Ye GL; Gao HL
World J Gastrointest Oncol; 2023 Aug; 15(8):1424-1435. PubMed ID: 37663945
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic accuracy of the multi-target stool DNA test in detecting colorectal cancer: A hospital-based study.
Gao HL; Lv LB; Zhao WF; Lu QW; Fan JQ
World J Gastrointest Oncol; 2023 Jan; 15(1):102-111. PubMed ID: 36684047
[TBL] [Abstract][Full Text] [Related]
3. Noninvasive fecal testing for colorectal cancer.
Zou J; Xiao Z; Wu Y; Yang J; Cui N
Clin Chim Acta; 2022 Jan; 524():123-131. PubMed ID: 34756863
[TBL] [Abstract][Full Text] [Related]
4. Analysis of the effectiveness of two noninvasive fecal tests used to screen for colorectal cancer in average-risk adults.
Sharma T
Public Health; 2020 May; 182():70-76. PubMed ID: 32179290
[TBL] [Abstract][Full Text] [Related]
5. Multitarget stool DNA test compared with fecal occult blood test for colorectal cancer screening.
Yang C; Wu W; Yang Y; Yang X; Sun J; Zhang W; Liu K; Ying H; Jiang S; Yu X; Shi Y; Zhou Y; Zhu S; Xu Y; Ding Y; Xie L; Cai B; Xin X; Chen P; Zhao R; Wu Y
Oncol Lett; 2020 Aug; 20(2):1193-1200. PubMed ID: 32724359
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic Accuracy of Stool Tests for Colorectal Cancer Surveillance in Hodgkin Lymphoma Survivors.
Ykema B; Rigter L; Spaander M; Moons L; Bisseling T; Aleman B; de Boer JP; Lugtenburg P; Janus C; Petersen E; Roesink J; Raemaekers J; van der Maazen R; Lansdorp-Vogelaar I; Gini A; Verbeek W; Lemmens M; Meijer G; van Leeuwen F; Snaebjornsson P; Carvalho B; van Leerdam M
J Clin Med; 2020 Jan; 9(1):. PubMed ID: 31936745
[TBL] [Abstract][Full Text] [Related]
7. Cross-cultural validation of stool Based Colorectal cancer screening methods in the North West of Iran.
Dolatkhah R; Somi MH; Dastgiri S; Asghari Jafarabadi M; Mashhadi Abdolahi H; Shanehbandi D; Asadi M; Nezamdoust M; Dolatkhah N; Farassati F
Ann Med Surg (Lond); 2022 Apr; 76():103494. PubMed ID: 35345791
[TBL] [Abstract][Full Text] [Related]
8. Estimating the impact of differential adherence on the comparative effectiveness of stool-based colorectal cancer screening using the CRC-AIM microsimulation model.
Piscitello A; Saoud L; Fendrick AM; Borah BJ; Hassmiller Lich K; Matney M; Ozbay AB; Parton M; Limburg PJ
PLoS One; 2020; 15(12):e0244431. PubMed ID: 33373409
[TBL] [Abstract][Full Text] [Related]
9. PPV and Detection Rate of mt-sDNA Testing, FIT, and CT Colonography for Advanced Neoplasia: A Hierarchic Bayesian Meta-Analysis of the Noninvasive Colorectal Screening Tests.
Pickhardt PJ; Correale L; Hassan C
AJR Am J Roentgenol; 2021 Oct; 217(4):817-830. PubMed ID: 33703913
[No Abstract] [Full Text] [Related]
10. Inappropriate Multi-Target Stool DNA Use for Colorectal Cancer Screening: Risks, Compliance, and Outcomes.
Lazar NJ; Khreisat A; AlKloub R; Al-Hillan A; Duffy M
Cureus; 2023 Jun; 15(6):e40506. PubMed ID: 37397671
[TBL] [Abstract][Full Text] [Related]
11. Multi-Target Stool DNA Testing for Colorectal Cancer Screening: Emerging Learning on Real-world Performance.
Eckmann JD; Ebner DW; Kisiel JB
Curr Treat Options Gastroenterol; 2020 Mar; 18(1):109-119. PubMed ID: 31965446
[TBL] [Abstract][Full Text] [Related]
12. Multitarget Stool DNA Test Performance in an Average-Risk Colorectal Cancer Screening Population.
Bosch LJW; Melotte V; Mongera S; Daenen KLJ; Coupé VMH; van Turenhout ST; Stoop EM; de Wijkerslooth TR; Mulder CJJ; Rausch C; Kuipers EJ; Dekker E; Domanico MJ; Lidgard GP; Berger BM; van Engeland M; Carvalho B; Meijer GA
Am J Gastroenterol; 2019 Dec; 114(12):1909-1918. PubMed ID: 31764091
[TBL] [Abstract][Full Text] [Related]
13. Clinical performance of an automated stool DNA assay for detection of colorectal neoplasia.
Lidgard GP; Domanico MJ; Bruinsma JJ; Light J; Gagrat ZD; Oldham-Haltom RL; Fourrier KD; Allawi H; Yab TC; Taylor WR; Simonson JA; Devens M; Heigh RI; Ahlquist DA; Berger BM
Clin Gastroenterol Hepatol; 2013 Oct; 11(10):1313-8. PubMed ID: 23639600
[TBL] [Abstract][Full Text] [Related]
14. Fecal Multidimensional Assay for Non-Invasive Detection of Colorectal Cancer: Fecal Immunochemical Test, Stool DNA Mutation, Methylation, and Intestinal Bacteria Analysis.
Mo S; Wang H; Han L; Xiang W; Dai W; Zhao P; Pei F; Su Z; Ma C; Li Q; Wang Z; Cai S; Wang H; Liu R; Cai G
Front Oncol; 2021; 11():643136. PubMed ID: 33718241
[TBL] [Abstract][Full Text] [Related]
15. Multitarget Stool DNA Testing Has High Positive Predictive Value for Colorectal Neoplasia on the Second Round of Testing.
Voss JK; Ebner DW; Burger KN; Mahoney DW; Devens ME; Lowrie KL; Kisiel JB
Clin Gastroenterol Hepatol; 2023 Aug; 21(9):2399-2406. PubMed ID: 36621751
[TBL] [Abstract][Full Text] [Related]
16. USPSTF colorectal cancer screening guidelines: an extended look at multi-year interval testing.
Berger BM; Parton MA; Levin B
Am J Manag Care; 2016 Feb; 22(2):e77-81. PubMed ID: 26881323
[TBL] [Abstract][Full Text] [Related]
17. Screening for Colorectal Cancer Using a Multitarget Stool DNA Test: Modeling the Effect of the Intertest Interval on Clinical Effectiveness.
Berger BM; Schroy PC; Dinh TA
Clin Colorectal Cancer; 2016 Sep; 15(3):e65-74. PubMed ID: 26792032
[TBL] [Abstract][Full Text] [Related]
18. Projecting total costs and health consequences of increasing mt-sDNA utilization for colorectal cancer screening from the payer and integrated delivery network perspectives.
Hathway JM; Miller-Wilson LA; Jensen IS; Ozbay B; Regan C; Jena AB; Weinstein MC; Parks PD
J Med Econ; 2020 Jun; 23(6):581-592. PubMed ID: 32063100
[No Abstract] [Full Text] [Related]
19. Initial validation of a self-report questionnaire based on the Theoretical Domains Framework: determinants of clinician adoption of a novel colorectal cancer screening strategy.
Zhu X; Lee MK; Weiser E; Griffin JM; Limburg PJ; Finney Rutten LJ
Implement Sci Commun; 2021 Oct; 2(1):119. PubMed ID: 34666841
[TBL] [Abstract][Full Text] [Related]
20. Combined Non-Invasive Prediction and New Biomarkers of Oral and Fecal Microbiota in Patients With Gastric and Colorectal Cancer.
Zhang C; Hu A; Li J; Zhang F; Zhong P; Li Y; Li Y
Front Cell Infect Microbiol; 2022; 12():830684. PubMed ID: 35663463
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
